For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Gastritis symptom improvement does not reliably follow Helicobacter eradication
+Print Archive
PRACTICE
Gastritis symptom improvement does not reliably follow Helicobacter eradication
Wednesday 13 February 2019, 12:30 AM

Electron microscopy image of H. pylori organisms showing their close association with gastric epithelial cells
GASTROENTEROLOGY
Auckland gastroenterologist Alan Fraser takes the case of a man with bad symptoms from gastritis but no improvement after Helicobacter eradication treatment, to illustrate some important knowledge and changing practice in this area
Key points, H. pylori eradication to prevent gastric cancer in targeted groups with a high risk of gastric cancer is cost effective
Gastritis is not a use
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.